Literature DB >> 24971705

RRE-dependent HIV-1 Env RNA effects on Gag protein expression, assembly and release.

Claudia S López1, Rachel Sloan2, Isabel Cylinder2, Susan L Kozak3, David Kabat3, Eric Barklis4.   

Abstract

The HIV-1 Gag proteins are translated from the full-length HIV-1 viral RNA (vRNA), whereas the envelope (Env) protein is translated from incompletely spliced Env mRNAs. Nuclear export of vRNAs and Env mRNAs is mediated by the Rev accessory protein which binds to the rev-responsive element (RRE) present on these RNAs. Evidence has shown there is a direct or indirect interaction between the Gag protein, and the cytoplasmic tail (CT) of the Env protein. Our current work shows that env gene expression impacts HIV-1 Gag expression and function in two ways. At the protein level, full-length Env expression altered Gag protein expression, while Env CT-deletion proteins did not. At the RNA level, RRE-containing Env mRNA expression reduced Gag expression, processing, and virus particle release from cells. Our results support models in which Gag is influenced by the Env CT, and Env mRNAs compete with vRNAs for nuclear export.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Env; Gag; HIV-1; RNA export; RRE

Mesh:

Substances:

Year:  2014        PMID: 24971705      PMCID: PMC4125522          DOI: 10.1016/j.virol.2014.05.019

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  57 in total

1.  The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions.

Authors:  T Murakami; E O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene.

Authors:  E Kotsopoulou; V N Kim; A J Kingsman; S M Kingsman; K A Mitrophanous
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins.

Authors:  D H Gabuzda; A Lever; E Terwilliger; J Sodroski
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

4.  Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions.

Authors:  X Yu; X Yuan; M F McLane; T H Lee; M Essex
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

5.  Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity.

Authors:  K A Page; N R Landau; D R Littman
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

6.  Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail.

Authors:  T Murakami; E O Freed
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles.

Authors:  D J Wyma; A Kotov; C Aiken
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

8.  Recruitment of the Crm1 nuclear export factor is sufficient to induce cytoplasmic expression of incompletely spliced human immunodeficiency virus mRNAs.

Authors:  Rui Yi; Hal P Bogerd; Bryan R Cullen
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

9.  Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant.

Authors:  C T Wang; Y Zhang; J McDermott; E Barklis
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation.

Authors:  Y Li; H Hui; C J Burgess; R W Price; P M Sharp; B H Hahn; G M Shaw
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

View more
  6 in total

1.  Analysis of HIV-1 Gag protein interactions via biotin ligase tagging.

Authors:  Christopher Ritchie; Isabel Cylinder; Emily J Platt; Eric Barklis
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

2.  Analysis of K-Ras Interactions by Biotin Ligase Tagging.

Authors:  Christopher Ritchie; Andrew Mack; Logan Harper; Ayna Alfadhli; Philip J S Stork; Xiaolin Nan; Eric Barklis
Journal:  Cancer Genomics Proteomics       Date:  2017 Jul-Aug       Impact factor: 4.069

3.  Analysis of quinolinequinone reactivity, cytotoxicity, and anti-HIV-1 properties.

Authors:  Ayna Alfadhli; Andrew Mack; Logan Harper; Sam Berk; Christopher Ritchie; Eric Barklis
Journal:  Bioorg Med Chem       Date:  2016-09-12       Impact factor: 3.641

4.  Lipid biosensor interactions with wild type and matrix deletion HIV-1 Gag proteins.

Authors:  Eric Barklis; August O Staubus; Andrew Mack; Logan Harper; Robin Lid Barklis; Ayna Alfadhli
Journal:  Virology       Date:  2018-03-15       Impact factor: 3.616

5.  Capsid-specific nanobody effects on HIV-1 assembly and infectivity.

Authors:  Ayna Alfadhli; CeAnn Romanaggi; Robin Lid Barklis; Ilaria Merutka; Timothy A Bates; Fikadu G Tafesse; Eric Barklis
Journal:  Virology       Date:  2021-07-05       Impact factor: 3.513

6.  Membrane-Active Sequences within gp41 Membrane Proximal External Region (MPER) Modulate MPER-Containing Peptidyl Fusion Inhibitor Activity and the Biosynthesis of HIV-1 Structural Proteins.

Authors:  Si Min Zhang; Alenka Jejcic; James P Tam; Anders Vahlne
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.